Navigation Links
Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2013
Date:11/7/2013

llion for the first nine months of 2013, compared to $65.5 million in the same period in the prior year. This increase included an additional investment of approximately $9.9 million in diagnostic inventory for safety stock to support expanded test capacity and commencement of commercial operations in the Sequenom Laboratories North Carolina facility. While we expect cash burn to fluctuate on a quarterly basis, we expect the cash burn to decline as collections and revenues increase.

The Company also used cash for capital investments of $11.7 million and debt repayments of $5.5 million during the first nine months of 2013. As of September 30, 2013, total cash, cash equivalents, and marketable securities were $84.7 million.

Operational UpdatesThe annualized run rate for the MaterniT21 PLUS test at the end of the third quarter continued to exceed 150,000 samples, despite the reduction in the Medicaid tests accessioned. Sequenom Laboratories believes it will meet its goal of 150,000 samples for the year. "We believe that we continue to be the market leader in NIPT. Based upon our volume and our understanding of the marketplace, we estimate that we have over 60% unit share of the U.S. high-risk pregnancy market," according to William J. Welch, President and Chief Operating Officer.

Sequenom Laboratories continues negotiations with the payor community. As of September 30, 2013, agreements had been executed that cover approximately 90 million lives for the MaterniT21 PLUS test. Importantly, we are receiving payments as an in-network or out-of-network provider from all of the major national payors.

Last month, Sequenom Laboratories announced an important addition to the MaterniT21 PLUS test, a significant achievement and testament to the laboratory's ongoing research and development efforts. This improvement, called the Enhanced Sequencing Series, ushers in a new era for noninvasive testing. With the ability to detect subchromosomal changes, the
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Sequenom, Inc. Announces Date Of Third Quarter 2013 Financial Results And Conference Call
2. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
3. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
4. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
5. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
6. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
7. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
8. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
9. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
10. ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013
11. NxStage Reports Third Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Breckenridge Pharmaceutical, Inc. announced today that ... Laboratories Pvt. Ltd. ( Hyderabad, India ) ... new ANDAs.  Under the terms of the agreement, MSN ... Breckenridge for the U.S. market, and Breckenridge will market ... MSN have agreed to develop an oral antibiotic with ...
(Date:12/19/2014)... , Dec. 19, 2014 In today,s ... product,s web presence to reflect the needs of ... particular, must meet the needs of key stakeholders ... According to recent research by ... of the participating companies averaged more than $100,000 ...
(Date:12/19/2014)... WESTMINSTER, Colo. , Dec. 19, 2014  Monarch ... (f/k/a Cannabis Kinetics Corp.) is pleased to provide this ... for continued growth in 2015. "Over this ... corporate goals and I am extremely proud to say ... diversified position today than it has ever been," stated ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Building a Best-in-Class Pharma Global Brand Website 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3
... in September -, BRISBANE, Calif., Sept. 4 ... that the amended Clinical Trial,Authorization (CTA) related to ... been approved by the appropriate European regulatory,authorities. InterMune ... the institutions that will conduct the Phase 1b ...
... Carlo brings predictability to whole range ... of Phase II, III and IV ... Solutions, a,global leader in off-the-shelf and custom supply chain ... announced,the release of its tcVisualize(TM) 3.0 clinical trial supply ...
Cached Medicine Technology:InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191 2InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191 3Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2
(Date:12/20/2014)... Recently, VogueQueen.com, a leading wedding dress ... Sale Online for 2015. Great discounts are now ... old consumers can get a discount, up to 80% ... website before January 30, 2015. , VogueQueen.com has recently ... a prom dress promotion. Many customers worldwide like VogueQueen’s ...
(Date:12/20/2014)... December 20, 2014 The Doctor’s Office Urgent ... the better part of a decade. They’ve treated over ... better, faster healthcare alternative to the Paramus area. ... three new additions to their staff of top-notch board certified ... Zeiger MD. These new doctors will work tirelessly ...
(Date:12/20/2014)... 20, 2014 Angeldress.co.uk, the distinguished wedding ... for worldwide dress fans. The company has recently updated ... information. For the holiday season, Angeldress Blog ... wedding apparel. , Angeldress.co.uk prides itself in offering a ... of service. All the company’s outfits are very carefully ...
(Date:12/20/2014)... 20, 2014 As Risperdal lawsuits ... in U.S. courts, Bernstein Liebhard LLP notes the ... children treated with the medication may experience elevated ... development and lactation. The study, which appears in ... adolescents who began treatment with risperidone, an antipsychotic ...
(Date:12/20/2014)... 2014 Atore, Inc, (San Francisco, CA ... first birthday focused portal on December 17th, 2014. ... in both US and Japan. , MERRY BIRTHDAY SITE ... http://merrybirthday.net/message/ , MERRY BIRTHDAY MESSAGE is part of ... world. , Features, Choose from thousands of stock photos ...
Breaking Medicine News(10 mins):Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Atore, Inc. Releasing the First Birthday Portal 2
... In an effort to extend the length of a ... Baptist Medical Center are partnering with colleagues from across the ... by the US National Institute on Aging (NIA). ... aims to assess whether aspirin can not only prolong life, ...
... HealthDay Reporter , WEDNESDAY, July 7 (HealthDay News) ... cancer is less accurate when done in the summer than ... Although the particular brand of test used in the ... the United States, the findings are of interest to U.S. ...
... ... FDA reports of the shocking conditions in manufacturing plants have pediatricians and parents concerned ... ... the year there have been numerous recalls of infants’ and children’s over-the-counter (OTC) pharmaceutical ...
... detection today is X-ray mammography, which takes images of ... are several disadvantages to using X-rays for breast cancer ... and the high costs, which limit their wide use ... depending on the age of the patient and tissue ...
... D.C. (July 1, 2010) -- Thousands of scientists and ... meet at the 52nd meeting of the American Association ... 22, 2010 in Philadelphia, Pennsylvania. They will present the ... and discuss the safety and regulatory issues facing the ...
... , WEDNESDAY, July 7 (HealthDay News) -- ... chronic low back pain influence how they manage their ... ability to find, understand and use health information. Low ... in many chronic conditions, but this relationship has not ...
Cached Medicine News:Health News:Can aspirin prolong a healthy life? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 3Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 4Health News:Safety in Children's Pain Relief Products a Primary Concern 2Health News:Safety in Children's Pain Relief Products a Primary Concern 3Health News:Mathematical models for breast cancer detection with microwave tomography are cheaper and less risky 2Health News:Understanding Back Pain May Improve Management, Study Suggests 2
... with wireless connectivity, ,The wireless functionality ... monitoring system that makes it possible to ... to the S/5 Central Station via Wireless ... flexible way of providing continuous centralized surveillance ...
... Metabolic Monitoring, ,The Deltatrac II is ... easy-to-use bedside unit. It's ideal for use ... is equally suited to both spontaneously breathing ... ,The individual nutritional needs of critically ...
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring core temperature and heart and breath sounds....
Medicine Products: